As per the results of the Tobit regression model, the health-state utility of patients with HER-2 positive breast cancer was significantly associated with their age, education level, monthly income, stage of cancer (non-metastatic or metastatic), EQ-VAS score, and DASS-10 score. This evidence concerns the gene ERBB2 and cancer.